Skip to Content

50% Dextrose Injection

Last Updated: April 8, 2021
Status: Resolved

Reason for the Shortage
    • Amphastar had 50% dextrose injection on allocation due to increased demand.
    • Pfizer had 50% dextrose injection on shortage due to manufacturing delays.
Available Products
    • 50% Dextrose intravenous injection, Amphastar, 50 mL Luer-Jet syringe, 10 count, NDC 76329-3301-01
    • 50% Dextrose intravenous injection, Pfizer, 50 mL LifeShield syringe, 10 count, NDC 00409-4902-34
    • 50% Dextrose intravenous injection, Pfizer, 50 mL Ansyr II Luer Lock syringe, 10 count, NDC 00409-7517-16
    • 50% Dextrose intravenous injection, Pfizer, 50 mL vial, 25 count, NDC 00409-6648-02

Estimated Resupply Dates

    • All marketed presentations are available.

Safety

    • FDA has extended the expiration dating for certain lots of 50% dextrose 50 mL Abboject syringes. https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm563360.htm

Updated

Updated April 8, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 20, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.